Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05197309 · ClinicalTrials.gov registry record · NA

Metabolic Diet for Relapse Prevention in Anorexia Nervosa

A NA study of Anorexia Nervosa, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05197309 is a NA study of Anorexia Nervosa that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 20 participants, below the 950-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05197309, a NA study of Anorexia Nervosa, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This is an interventional study that will test the safety, tolerability, and efficacy of the Metabolic Diet, which was designed as a treatment for women with anorexia nervosa to remain weight-stable after they have been restored from low weight. Participants will be adult women with anorexia nervosa who have been recently restored to normal weight and adult women with no history of eating disorders. After enrollment, participants will start meeting weekly with a registered dietitian to implement the Metabolic Diet in their daily lives, and will receive medical monitoring for adherence, side effects, changes in metabolic or psychological parameters, and weight stability.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Metabolic Diet

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-11-20
Est. Completion 2026-12
Phase NA

What the Registry Record Tells You About NCT05197309

The ClinicalTrials.gov registry entry for NCT05197309 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 950-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (98% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anorexia Nervosa appearing as the primary indexed condition, and to 1 intervention - of which Metabolic Diet is the first listed.

NCT05197309 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05197309 about?

NCT05197309 is a clinical study titled "Metabolic Diet for Relapse Prevention in Anorexia Nervosa". This is an interventional study that will test the safety, tolerability, and efficacy of the Metabolic Diet, which was designed as a treatment for women with anorexia nervosa to remain weight-stable after they have been restored from low weight. Participants will be adult women with anorexia nervosa...

What is the current status of trial NCT05197309?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-11-20. Estimated completion is 2026-12.

What conditions does trial NCT05197309 study?

This clinical trial studies the following conditions: Anorexia Nervosa.

What interventions are being tested in trial NCT05197309?

The interventions under investigation include: Metabolic Diet (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05197309?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05197309 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.